- Home
-
Learn, develop, connect
-
Membership
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information -
About us
News Archive
Safety Observer - RSI in Clinical Trials: MHRA Findings and Tips
22nd March 2022Safety Observer Article - RSI in Clinical Trials: MHRA Findings and Tips
UKRI - Shared commitment to improve public involvement in research
22nd March 2022UK Research and Innovation (UKRI) has signed a shared commitment to improve public involvement in health and social care research.
MHRA Blog - Compliance Monitor process (Part 1) – An introduction
16th March 2022Compliance Monitor process (Part 1) – An introduction
EC - Political and legal issues linked to financing the development of pharmaceuticals all along their life-cycle
10th March 2022Presentations and recording - HPP webinar: “Political and legal issues linked to financing the development of pharmaceuticals all along their life-cycle” (03 March 2021)
EMA - Regulation on EMA’s extended mandate becomes applicable
10th March 2022The regulation reinforcing EMA’s role in crisis preparedness and management of medicinal products and medical devices becomes applicable as of 1st March 2022. It puts some of the structures and processes established by EMA during the COVID-19 pandemic on a more permanent footing, while entrusting several new tasks to the Agency.
EMA - Highlights of 2021
10th March 2022Human and Veterinary Highlights from 2021
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
10th March 2022Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
EMA - PRIME enables earlier availability of life-changing medicines
10th March 2022EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines.
FDA - New bill seeks to revamp FDA’s accelerated approvals programme
10th March 2022New bill seeks to revamp FDA’s accelerated approvals programme
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 2022
10th March 2022Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 2022
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us